International Journal of Technology Assessment in Health Care

Article	Citations
The new definition of health technology assessment: A milestone in international collaboration	215
Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	79
Health technology assessment frameworks for eHealth: A systematic review	43
Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders	34
Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward	32
Principles for deliberative processes in health technology assessment	29
Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?	26
Real-world evidence use in assessments of cancer drugs by NICE	24
Patient and public involvement in health technology assessment: update of a systematic review of international experiences	24
The effects of mobile apps on stress, anxiety, and depression: overview of systematic reviews	23
The broader societal impacts of COVID-19 and the growing importance of capturing these in health economic analyses	21
Health technology assessment for digital technologies that manage chronic disease: a systematic review	20
Cost-effectiveness evaluation for pricing medicines and devices: A new value-based price adjustment system in Japan	19
Development of a checklist to guide equity considerations in health technology assessment	17
Development of a health technology assessment module for evaluating mobile medical applications	15
Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements	15
The link between health technology assessment and decision making for the allocation of health resources in Latin America	14
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal	14
Early economic evaluation to guide the development of a spectroscopic liquid biopsy for the detection of brain cancer	13
Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops	13
Exploring the identification, validation, and categorization of costs and benefits of education in mental health: The PECUNIA project	13
Evaluation of 3D printing costs in surgery: a systematic review	12
On the integration of early health technology assessment in the innovation process: reflections from five stakeholders	12
Beyond the numbers: a critique of quantitative multi-criteria decision analysis	12
Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story	11

An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency	11
Mind the evidence gap: the use of patient-based evidence to create “complete HTA” in the twenty-first century	11
Economic evaluation guidelines in low- and middle-income countries: a systematic review	11
Measuring patient satisfaction with video consultation: a systematic review of assessment tools and their measurement properties	11
Considering and communicating uncertainty in health technology assessment	11
A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic	11
Exploring the identification, validation, and categorization of the cost and benefits of criminal justice in mental health: the PECUNIA project	10
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements	10
Systematic review search methods evaluated using the Preferred Reporting of Items for Systematic Reviews and Meta-Analyses and the Risk Of Bias In Systematic reviews tool	9
Evaluation of the impact of patient input in health technology assessments at NICE	9
Addressing the challenges of implementing a Health Technology Assessment Policy Framework in South Africa	9
COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection	9
PP424 Piloting A Comprehensive Search For eHealth Definitions In The Grey Literature: Preliminary Results From A Systematic Scoping Review	9
Developing a quality management system for the European Network for Health Technology Assessment (EUnetHTA): toward European HTA collaboration	9
The NICE MEDLINE and Embase (Ovid) health apps search filters: development of validated filters to retrieve evidence about health apps	9
Model for ASsessing the value of Artificial Intelligence in medical imaging (MAS-AI)	8
Value of mesenchymal stem cell therapy for patients with septic shock: an early health economic evaluation	8
How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations	8
Cost-effectiveness of treating head and neck cancer using intensity-modulated radiation therapy: implications for cancer control program in India	8
The estimation of health state utility values in rare diseases: overview of existing techniques	8
Environmental impact assessment in health technology assessment: principles, approaches, and challenges	8
A review of HTA guidelines on societal and novel value elements	8
Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach	8
Examining the impact of different country processes for appraising rare disease treatments: a case study analysis	7
A different animal? Identifying the features of health technology assessment for developers of medical technologies	7
Patient involvement in relative effectiveness assessments in the European Network for Health Technology Assessment	7
NICE's evaluations of medicines authorized by EMA with conditional marketing authorization or under exceptional circumstances	7
Application of a health technology assessment framework to digital health technologies that manage chronic disease: a systematic review	7
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force	7
Developing recommendations for the diagnosis and treatment of Lyme disease: the role of the patient's perspective in a controversial environment	7
The learning curve in transcatheter aortic valve implantation clinical studies: A systematic review	6
Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?	6
On the role of cost-effectiveness thresholds in healthcare priority setting	6
Peer review of searches for studies for health technology assessments, systematic reviews, and other evidence syntheses	6
Can multi-criteria decision analysis (MCDA) be implemented into real-world drug decision-making processes? A Canadian provincial experience	6
Determinants of Managed Entry Agreements in the context of Health Technology Assessment: a comparative analysis of oncology therapies in four countries	6
Analysis of PBAC submissions and outcomes for medicines (2010–2018)	6
Implementation of a new Digi-HTA process for digital health technologies in Finland	6
Economic impact of the use of the National Surgical Quality Improvement Program	6
Relevance of the newly defined Health Technology Assessment: COVID-19 and beyond	5
A framework for action to improve patient and public involvement in health technology assessment	5
Prioritizing critical-care resources in response to COVID-19: lessons from the development of Thailand's Triage protocol	5
Stakeholder preferences for attributes of digital health technologies to consider in health service funding	5
A toolkit of methods of development-focused health technology assessment	5
Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices	5
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework	5
Assessing the capacity of Ghana to introduce health technology assessment: a systematic review of economic evaluations conducted in Ghana	5
A model-based study to estimate the health and economic impact of health technology assessment in Thailand	5
Toward a common understanding of competencies for health technology assessment: enhancing educational and training programs around the globe	5
Health technology assessment applied to emergency preparedness: a new perspective	5

Patient and public involvement in Health Technology Assessment: a new dawn?	5
Evaluation of patient involvement strategies in health technology assessment in Spain: the viewpoint of HTA researchers	5
Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies	5
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities	4
Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment	4
Quality of health economic evaluations submitted to the Italian Medicines Agency: current state and future actions	4
Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health	4
Tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia in the Irish healthcare setting: cost-effectiveness and value of information analysis	4
Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries	4
Incorporating environmental and sustainability considerations into health technology assessment and clinical and public health guidelines: a scoping review	4
Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations	4
Technology assessment framework for precision health applications	4
Collaboration applications for mixed home care — A systematic review of evaluations and outcomes	4
Cost-effectiveness analysis of magnetic resonance-guided focused ultrasound ablation for palliation of refractory painful bone metastases	4
Postlaunch evidence-generation studies for medical devices in Spain: the RedETS approach to integrate real-world evidence into decision making	4
Physician–patient shared decision making, patient satisfaction, and adoption of new health technology in China	4
Health Technology Assessment in Support of National Health Insurance in South Africa	4
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”	3
Desirability and acceptability of a treatment-sequencing model in relapsing-remitting multiple sclerosis: A health technology assessment perspective	3
Systems thinking in health technology assessment: a scoping review	3
Evaluating physicians’ perspectives on the efficiency and effectiveness of the electronic prescribing system	3
Integration of ethical considerations into HTA reports: an analysis of integration levels using a systematic review	3
Development of a decisional flowchart for meaningful patient involvement in Health Technology Assessment	3
Evidence-based searching for health technology assessment: keeping up to date with SuRe Info	3
Redefining Health Technology Assessment: A Comment on “The New Definition of Health Technology Assessment: A Milestone in International Collaboration”	3
Development of an international template to support patient submissions in Health Technology Assessments	3
Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review	3
Early Dialogues for Pharmaceutical Products in European Network for Health Technology Assessment Joint Action 3: What Was Done and Where to Go in the Future	3
The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies	3
Creating enriched training sets of eligible studies for large systematic reviews: the utility of PubMed's Best Match algorithm	3
Values, principles, strategies, and frameworks underlying patient and public involvement in health technology assessment and guideline development: a scoping review	3
Integrating Early Economic Evaluation into Target Product Profile development for medical tests: advantages and potential applications	3
Health technology assessment: A matter of facts and values	3
Overview of information retrieval in a hospital-based health technology assessment center in a Swedish region	3
Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks	3
Evaluating traditional and complementary medicines: Where do we go from here?	3
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review	3
Establishment and implementation of hospital-based health technology assessment at King Hussein Cancer Center: can our model be an example?	3
Using discrete-choice experiments to elicit preferences for digital wearable health technology for self-management of chronic kidney disease	3
Pilot approach to analyzing patient and citizen involvement in health technology assessment in four diverse low- and middle-income countries	3
Assessment of technical errors and validation processes in economic models submitted by the company for NICE technology appraisals	3
How does HTA addresses current social expectations? An international survey	3
Lessons from the vaginal mesh scandal: enhancing the patient-centric approach to informed consent for medical device implantation	3
Developing an agency's position with respect to patient involvement in health technology assessment: the importance of the organizational culture	3
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group	3
Strengthening patient outcome evidence in health technology assessment: a coproduction approach	3
Effectiveness, efficacy, and safety of wearable cardioverter-defibrillators in the treatment of sudden cardiac arrest – Results from a health technology assessment	3
Addressing uncertainty in relative effectiveness assessments by HTA organizations	3
Qualitative comparative analysis of health economic evaluation guidelines for health technology assessment in European countries	3
Patient and caregiver engagement in the Patient-Centered Outcomes Research Institute (PCORI) Health Care Horizon Scanning System (HCHSS) process	2
Disruptive technologies in health care disenchanted: a systematic review of concepts and examples	2
Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body	2
Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3	2
Sustainability of healthcare systems in Asia: exploring the roles of horizon scanning and reassessment in the health technology assessment landscape	2
Topic selection process in health technology assessment agencies around the world: a systematic review	2
A review of implementation frameworks to operationalize health technology assessment recommendations for medical technologies in the Singapore setting	2
Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling	2
A HTA of what? Reframing through including patient perspectives in health technology assessment processes	2
Adherence to country-specific guidelines among economic evaluations undertaken in three high-income and middle-income countries: a systematic review	2
Postlaunch evidence generation practices among health technology assessment bodies in Europe	2
Evaluation of the impact of patient involvement in health technology assessments: A scoping review	2
A different animal but the same beast? Using development-focused health technology assessment to define the value proposition of medical technologies	2
The fourth edition of the European Network for Health Technology Assessment Forum: highlights and outcomes	2
Exploring facilitators and barriers to introducing health technology assessment: a systematic review	2
Demonstrating the influence of HTA: INAHTA member stories of HTA impact	2
Benchmarking health technology assessment agencies—methodological challenges and recommendations	2
Evaluation of precision medicine assessment reports of the Belgian healthcare payer to inform reimbursement decisions	2
A systematic literature review of revealed preferences of decision-makers for recommendations of cancer drugs in health technology assessment	2
The contribution of French patient and consumer groups to health technology assessments over a 2-year period: an observational retrospective study	2
Information specialist collaboration in Europe: collaborative methods, processes, and infrastructure through EUnetHTA	2
Core competencies for ethics experts in health technology assessment	2
Hospital-based health technology assessment in Brazil: current experiences and challenges	2
A framework for local-level economic evaluation to inform implementation decisions: health service interventions to prevent hospital-acquired hypoglycemia	2
Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach	2
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework – Corrigendum	2
Valuing Alzheimer's disease drugs: a health technology assessment perspective on outcomes	2
PD20 Real-World Evidence To Support Single Arm Trials Of Oncology Interventions: Necessity or ‘NICE’ (National Institute for Health and Care Excellence) to Have?	2
Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature	2
Test–retest reliability of the Cost for Patients Questionnaire	2
Projecting effectiveness after ending a randomized controlled trial: a two-state Markov microsimulation model	2

PP162 Digital Medication Health Service Platforms Of Pharmaceutical Companies As Novel Sources Of Real-World Data For Health Technology Assessment	2
Promoting health economic evaluation studies in the AYUSH system of medicine: the need of the hour	2
Disagreement on cancer drug decisions in Europe	2
Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation	2
Glycated hemoglobin as a surrogate for evaluating the effectiveness of drugs in diabetes mellitus trials: a systematic review and trial-level meta-analysis	2
Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project	2
Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System: the cefiderocol example	2
PP40 Health Apps To Manage Depression: Can We Separate The Grain From The Chaff? EvalDepApps Project	2
Key learnings from Institute for Clinical and Economic Review’s real-world evidence reassessment pilot	2
Disinvestment in healthcare: a scoping review of systematic reviews	2
Survey investigating the knowledge and awareness of payers and patient advocacy groups about the health technology assessment process in Lebanon	2
Physicians' perception toward non-invasive prenatal testing through the eye of the Rogers' diffusion of innovation theory in China	2
Understanding innovation of health technology assessment methods: the IHTAM framework	2
Economic evaluation of genomic/genetic tests: a review and future directions	2
Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of “Failed” R&D Efforts	2
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases	2
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis	1
OP223 A Semi-Automated Process To Monitor The Clinical Development And Regulatory Approval Pathway Of Innovative Medicines	1
Assessing the early impact of a hospital-based health technology assessment program, smart innovation	1
Impact of rarity on Canadian oncology health technology assessment and funding	1
PP261 Development Of A Mapping Algorithm To Predict SF-6D Values In People With Drug-Resistant Focal Onset Seizures	1
PP414 Improving The Accessibility Of Scottish Medicines Consortium Advice	1
PD45 Paying For Digital Health: What Evidence Is Needed?	1
Towards greater impact in health technology assessment: horizon scanning for new and emerging technologies in Singapore	1
OP535 Cost-Effectiveness Of Internet-Based HIV Screening In Men Who Have Sex With Men in Vancouver, British Columbia, Canada	1
Adjustment of publication bias using a cumulative meta-analytic framework	1
Review of real-world evidence studies in type 2 diabetes mellitus: Lack of good practices	1
Manufacturers’ perceptions of the decision-making process for new drug reimbursement in South Korea	1
Quality of economic evaluations of ventricular assist devices: A systematic review	1
OP01 Convergent Validity Between Discrete Choice Experiment And Other Stated Preference Methods: A Multistudy Comparison	1
PP70 Enhancing HTA Processes In The Maltese System For Introducing New Medicines	1
Early access schemes for innovative health technologies: the views of international stakeholders	1
Using INTEGRATE-HTA for the assessment of videorasterstereography in idiopathic scoliosis	1
Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective	1
PP228 Strategy For Including Information On The Research Priorities Of Patients And Experts In Health Technology Assessment Reports	1
Neglected impacts of patient decision-making associated with genetic testing	1
Identification and selection of health technologies for assessment by agencies in support of reimbursement decisions in Latin America	1
Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets	1
Do France, Germany, and Italy agree on the added therapeutic value of medicines?	1
Patient Perspectives: An Integral Part of Health Technology Assessment Methodology	1
Vínculo Entre La Evaluación De Tecnologías Sanitarias y La Toma De Decisión Para La Asignación De Recursos Sanitarios en Latino-América	1
OP520 Evaluating Long-Term Survival From Clinical Trials: Does Real-World Evidence Change the Paradigm?	1
Using social media research in health technology assessment: stakeholder perspectives and scoping review	1
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement	1
The development process of economic evaluation guidelines in low- and middle-income countries: a systematic review	1
A voice to be heard: patient and public involvement in health technology assessment and clinical practice guidelines in Malaysia	1
EUnetHTA relative effectiveness assessments: efforts to increase usability, transparency and inclusiveness	1
Informing decision makers about public preferences for different modalities of cancer treatment in the Rhône–Alps region in France	1
PP553 Study On The Utilization Of Medical Resources In Patients With Malignant Tumors in China	1
OP248 A Minimum Data-Set For Left Ventricular Assist Device On Destination Therapy: Cross-Border Collaboration Pilot On Real World Data	1
OP218 Searching Preprint Repositories For COVID-19 Therapeutics Using A Semi-Automated Text-Mining Tool	1
European Network for Health Technology Assessment’s Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics	1
Fit for the future? Status of health-related quality of life research in South Africa	1
Novel approach to decision making for orphan drugs	1
Community engagement in Health Technology Assessment and beyond: from guests in the process to hosts	1
Clinical effectiveness reporting of novel cancer drugs in the context of non-proportional hazards: a review of nice single technology appraisals	1
PP265 Application Of A Case-Mix Method For Medical Consumables Management In Anhui Province, China Using Healthcare Big Data	1
The rationale and design of public involvement in health-funding decision making: focus groups with the Canadian public	1
Expanding health technology assessment towards broader value: Ireland as a case study	1
PP290 Ongoing Swedish Initiatives To Improve The Potential For Real World Data Assessment Of Medical Devices	1
OP283 A Pipeline Analysis Of Advanced Therapy Medicinal Products (ATMPs) In Late-Stage Clinical Development	1
Beyond clinical and cost-effectiveness: The contribution of qualitative research to health technology assessment	1
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders	1
Best practice considerations on the assessment of robotic assisted surgical systems: results from an international consensus expert panel	1
Using early health economic modeling to inform medical innovation development: a soft robotic sock in poststroke patients in Singapore	1
A Technical Review of the ISPOR Presentations Database Identified Issues in the Search Interface and Areas for Future Development	1
Mecanismos de identificación y priorización de las tecnologías sanitarias a ser evaluadas por las Agencias de ETESA para decisiones de cobertura en Latino America	1
PD33 Development And Validation Of A Machine Learning-Based Prediction Model For COVID-19 Diagnosis Using Patients’ Metabolomic Profile Data	1
PP385 Using Common Data Models And Data Networks For Evidence Generation In Health Technology Assessment	1
Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews	1
Synthesizing quantitative and qualitative information on multiple comparisons of health interventions to facilitate knowledge transfer: an example from an EUnetHTA multi-HTA	1
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies	1
The cost of metastatic prostate cancer using time-driven activity-based costing	1
European collaboration on health technology assessment: looking backward and forward	1
Response to “UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP”	1
Lessons learned from the reimbursement policy for immune checkpoint inhibitors and real-world data collection in Taiwan	1
Bridging health technology assessment and healthcare quality improvement using international consortium of health outcomes measurement standard sets	1
International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market	1
PP434 Quality Of Studies Submitted To Support Requests For Medical Devices And Equipment Incorporation In A Teaching Hospital	1
PP90 Effectiveness Of Music Therapy For Autism Spectrum Disorder, Dementia, Depression, Insomnia, And Schizophrenia	1
Rapid qualitative evidence syntheses (rQES) in health technology assessment: experiences, challenges, and lessons	1
Involvement of information specialists and statisticians in systematic reviews	1
EUnetHTA’s contribution to the new legal framework for health technology assessment cooperation in Europe	1
Access to medicines in Turkey: Evaluation of the process of medicines brought from abroad	1
Opportunities to improve reporting of rapid response in health technology assessment	1
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect	1
PP531 Quality Of Life Of Patients With Long-Chain Fatty Acid Oxidation Disorders Before And During Treatment With Triheptanoin	1
Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults	1
Emerging healthcare interventions: Patient-Centered Outcomes Research Institute’s programmatic initiative	1
OP87 Value From A Multi-stakeholder Perspective: A Framework To Assess Digital Health Solutions For Improving Chronic Disease Management	1
A systematic review of economic evaluations for RPE65-mediated inherited retinal disease including HTA assessment of broader value	1
Mapping horizon scanning systems for medical devices: similarities, differences, and lessons learned	1
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities	1
PP399 Analysis Of Referral Patterns To Specialized Centers In Idiopathic Pulmonary Fibrosis To Define A New Regional Care Pathway	0
Ethics analysis of light and vitamin D therapies for seasonal affective disorder	0